- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06212544
An HIV Status-neutral Microeconomic Intervention (Secure)
June 4, 2025 updated by: Kristi Gamarel, University of Michigan
Strengthening Community Responses to Economic Vulnerability and HIV Inequities
The aim is the current study is to establish feasibility and acceptability of the SeCuRE intervention to improve HIV prevention and care continua outcomes. To meet this aim, the study has the following objectives:
- To deliver a two-armed pilot RCT of the SeCuRE intervention with 40 transgender women of color.
- The determine acceptability of the intervention with transgender women of color.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This is a two-arm randomized waitlist controlled trial in which transgender women of color will be randomly allocated to either the enhanced microeconomic intervention that builds on the Trans Sistas of Color Project's existing microeconomic interventions, which includes: (1) $250 in emergency assistance; and (2) peer support to obtain legal gender affirmation (i.e., legal name and gender markers on identification documents).
The existing intervention will be enhanced to include (1) 12 weekly educational group sessions on economic empowerment (i.e., job acquisition, income generation through micro-business, and financial literacy) and HIV prevention and care; (2) employment-focused mentoring; and (3) an unconditional grant ($1,200) for use towards acquiring self-led or formal employment.
Each condition will complete a baseline survey prior to randomization, a follow-up survey immediately following intervention completion, and 3-month survey after intervention completion.
Participants will also complete qualitative exit interviews within one month of completion of intervention completion for both conditions.
Study Type
Interventional
Enrollment (Actual)
39
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Michigan
-
Highland Park, Michigan, United States, 48203
- Ruth Ellis Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- at least 18 years old;
- assigned male at birth;
- self identifies as female, transgender woman, or another feminine gender identity;
- self identifies as a person of color (i.e., any racial/ethnic identity except non-Hispanic white);
- reports earning less than $32,800 gross annual income (current living wage in Michigan);
- reports condomless sex in the past 6 months;
- lives in Detroit, MI greater metropolitan area (~50 mile radius);
- speaks English.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Sequential Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Immediate Intervention
The intervention condition builds on our community partners' existing microeconomic intervention of: (1) a one-time emergency cash grant and (2) peer and legal support to obtain legal gender affirmation - plus a 12-week microeconomic intervention that adds: (3) weekly educational sessions and HIV prevention; (4) community mentoring; and (5) weekly posts of job openings in Detroit; and (6) a micro-grant for use towards acquiring self-led or formal employment
|
Enhanced microeconomic intervention
|
|
Active Comparator: Delayed Arm
Participants randomized to the control condition will receive UC during the 12-week period following randomization.
Usual care consists of emergency assistance and access to legal name/gender marker change.
After the RCT follow-up period is complete, waitlist control participants will be offered delayed access to the same intervention that is provided immediately to intervention arm participants.
|
Usual care and then access to enhanced microeconomic intervention
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Acceptability Quantitative
Time Frame: 3 months
|
The Client Satisfaction Questionnaire (CSQ-8) will be used to assess intervention satisfaction.
This is an 8-item scale where each individual item is scored separately with a range of 1 to 4 and a score of 3 or 4 on each item will be considered indicative of acceptable.
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Kristi Gamarel, PhD, University of Michigan
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 7, 2024
Primary Completion (Actual)
February 26, 2025
Study Completion (Actual)
February 26, 2025
Study Registration Dates
First Submitted
December 20, 2023
First Submitted That Met QC Criteria
January 13, 2024
First Posted (Actual)
January 19, 2024
Study Record Updates
Last Update Posted (Estimated)
June 5, 2025
Last Update Submitted That Met QC Criteria
June 4, 2025
Last Verified
June 1, 2025
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- F00423
- R34MH130207 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
The investigators plan to share de-identified data per guidelines; however, data will be in aggregate form to ensure individuals are not identified in anyway.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Feasibility Studies
-
University of UtahCompletedFeasibility StudiesUnited States
-
Coxa, Hospital for Joint ReplacementTampere UniversityNot yet recruiting
-
University of Maryland, BaltimoreNational Institute on Aging (NIA); The Claude D. Pepper Older Americans Independence...Recruiting
-
University of Southern DenmarkEuropean Research CouncilCompleted
-
Arizona State UniversityNational Institute on Drug Abuse (NIDA)RecruitingFeasibility Studies | AcceptabilityUnited States
-
Seven Oaks Hospital Chronic Disease Innovation...Not yet recruitingFeasibility Studies | Nutrition InterventionCanada
-
University of ChileBloomberg PhilanthropiesCompleted
-
Florida State UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA)RecruitingHealthy Participants | Feasibility Studies | AcceptabilityUnited States
-
Children's Hospital ColoradoChildren's Hospital Los AngelesRecruitingFeasibility Studies | Isolation | Inpatient Pediatric CareUnited States
-
Qassim UniversityRecruitingArtificial Intelligence | Feasibility Studies | Public HealthSaudi Arabia
Clinical Trials on Immediate Intervention
-
Holland Bloorview Kids Rehabilitation HospitalActive, not recruitingCerebral Palsy | Chronic PainCanada
-
University of MinnesotaNational Institute on Minority Health and Health Disparities (NIMHD)Completed
-
Unity Health TorontoSunnybrook Health Sciences Centre; University of Toronto; Durham Region Health...Completed
-
University of British ColumbiaBritish Columbia Cancer AgencyRecruiting
-
US Department of Veterans AffairsCompleted
-
University of Alabama at BirminghamNational Cancer Institute (NCI); Auburn UniversityCompleted
-
Craig HospitalNational Institute on Disability, Independent Living, and Rehabilitation...RecruitingCervical Spinal Cord InjuryUnited States
-
VA Greater Los Angeles Healthcare SystemUniversity of California, Los AngelesCompletedObstructive Sleep ApneaUnited States
-
Medical College of WisconsinUniversity of Illinois at Chicago; Loyola University Chicago; Marquette UniversityActive, not recruitingProstate CancerUnited States